| |
||
|
Catalogue Number |
Product | Order number / Unit |
| |
||
| 9750 | Octreotide acetate |
9750.0001: 1 mg per vial 9750.0010: 10 mg per vial Please inquire for customized filling and bulk quantities.
|
|
Potent somatostatin analog |
||
| Molar Mass: 1019.24 | ||
| C49H66N10O10S2 | ||
| [79517-01-4] | ||
| Colourless to off-white freeze-dried solid packaged in dark glass screw cap vials. | ||
| Purity: ≥ 98 % | ||
|
Certificates:
CoA; MS (identity) and HPLC (purity) |
||
|
Chemical Name: CA index name: L-Cysteinamide, D-phenylalanyl-L-cysteinyl-L-phenylalanyl-D-tryptophyl-L-lysyl-L-threonyl-N-[(1R,2R)-2-hydroxy-1-(hydroxymethyl)propyl]-, cyclic (2→7)-disulfide, acetate (salt) |
||
|
Synonymes: Octreotide acetate; Sandostatin; Sandostatin LAR; SMS 201-995ac |
||
|
Literature: 1. Yumi K. et al. Direct effects of somatostatin analaog octreotide on insulin-like growth factor-I in the aterial wall. Lab Invest. 1997, 76, 329. |
||
| 2. Okamoto E. et al. Effects of octreotide, a somatostatin analogue, on gastric function evaluated by real-time ultrasonography. Aliment Pharmacol Ther. 1997, 11, 177. | ||
| date of product catalogue issue: 05 April 2012 | ||
PDF file product list home page search email legal notice
ICP License: 沪ICP备05000469号-1